olaquindox has been researched along with Infections, Klebsiella in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bonomo, RA; Chen, L; Coakley, P; Hujer, AM; Kreiswirth, BN; Marshall, SH; Paterson, DL; Perez, F; Rather, PN; Rudin, SD; Toltzis, P; van Duin, D | 1 |
1 other study(ies) available for olaquindox and Infections, Klebsiella
Article | Year |
---|---|
OqxAB, a quinolone and olaquindox efflux pump, is widely distributed among multidrug-resistant Klebsiella pneumoniae isolates of human origin.
Topics: Americas; Animals; Anti-Bacterial Agents; Asia; Australia; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Genes, MDR; Humans; Klebsiella Infections; Klebsiella pneumoniae; Quinolones; Quinoxalines; Swine; Swine Diseases | 2013 |